Follicular helper T cells in immunity and systemic autoimmunity - PubMed (original) (raw)
Review
Follicular helper T cells in immunity and systemic autoimmunity
Joseph E Craft. Nat Rev Rheumatol. 2012.
Abstract
Follicular helper T (T(FH)) cells are essential for B-cell maturation and immunoglobulin production after immunization with thymus-dependent antigens. Nevertheless, the development and function of T(FH) cells have been less clearly defined than classic CD4(+) effector T-cell subsets, including T-helper-1 (T(H)1), T(H)2 and T(H)17 cells. As such, our understanding of the genesis of T(FH) cells in humans and their role in the development of autoimmunity remains incomplete. However, evidence from animal models of systemic lupus erythematosus (SLE) and patients with systemic autoimmune diseases suggests that these cells are necessary for pathogenic autoantibody production, in a manner analogous to their role in promotion of B-cell maturation during normal immune responses. In this Review, I discuss the findings that have increased our knowledge of T(FH)-cell development and function in normal and aberrant immune responses. Such information might improve our understanding of autoimmune diseases, such as SLE, and highlights the potential of T(FH) cells as therapeutic targets in these diseases.
Conflict of interest statement
Competing interests
The author declares no competing interests.
Figures
Figure 1
The CD4+ T cell development paradigm. Differentiation of naive CD4+ T cells into different T-helper-cell subsets is dependent on factors present in the local environment, most prominently cytokines. The specific stimulatory conditions influence transcription factor expression, which determines the differentiation program that the T cell will follow and thus the cytokines that it will subsequently produce. The pattern of cytokine expression characterizes the individual T-helper-cell subsets and dictates their function in host defenses. Whereas the cytokine signals that promote the development of TH1, TH2, TH17, and TREG cells are well-defined, less is known about those that drive TFH-cell formation, but seem to include IL-6 and IL-21. Abbreviations: BCL6, B-cell lymphoma 6; FOXP3, forkhead box protein 3; GATA3, GATA-binding factor 3; RORα, retinoid-related orphan receptor-α; RORγt, retinoid-related orphan receptor-γt; TBX21, T-box transcription factor TBX21; TFH, follicular helper T; TGF-β, transforming growth factor-β; TH1, T-helper-1; TH2, T-helper-2; TH17, T-helper-17; TREG, regulatory T.
Figure 2
TFH-cell development and TFH-cell–B-cell collaboration in extrafollicular and GC responses. Naive T cells migrate to the T-cell zones of secondary lymphoid organs (here, the spleen) following a chemokine gradient of CCL19 and CCL21 that engages CCR7 on their surface (1). B cells localize to the B-cell follicle, directed by CXCL13 that engages CXCR5 on their plasma membrane (1). Upon antigen activation and co-stimulation by dendritic cells, nascent TFH cells upregulate CXCR5, downregulate CCR7 and migrate to the T-cell–B-cell border (or interfollicular regions of lymph nodes), where they contact antigen-activated B cells that move towards the T-cell zone after upregulating CCR7 (2). The outcome of this interaction is development of extrafollicular foci (3), where short-lived plasmablasts produce antibodies, or GCs in the B-cell follicle (3). In both structures, TFH cells promote B-cell maturation, inducing class switching and affinity selection, via cytokines —particularly IL-21 and IL-4—and cell-bound molecules—including CD40 ligand (4). TFH-cell and GC B-cell development and function are dependent on the transcriptional regulator BCL6. The GC response leads to memory B cell and plasma cell formation (5). Abbreviations: BCL6, B-cell lymphoma 6; CCL19, CC-chemokine ligand 19; CCL21, CC-chemokine ligand 21; CCR7, CC-chemokine receptor 7; CXCL13, CXC-chemokine ligand 13; CXCR5, CXC-chemokine receptor 5; GC, germinal centre; TFH, follicular helper T.
Figure 3
The interaction between TFH cells and GC B cells. The former express molecules critical for survival and for maturation of the latter to memory B cells and plasma cells that produce class-switched immunoglobulin, including CD40L signaling via CD40 and the cytokines IL-4 and IL-21 signaling via their receptors. PD-1 on TFH cells, via binding to its ligands on GC B cells, PD-L1 and especially PD-L2, promotes survival and selection of the latter cells. Abbreviations: BCR, B-cell receptor; CD40L, CD40 ligand; GC, germinal centre; ICOS, inducible T-cell co-stimulator; ICOS-L, inducible T-cell co-stimulator ligand; Ig, immunoglobulins; IL-4R, IL-4 receptor; IL-21R, IL-21 receptor; MHC, major histocompatibility complex; PD-1, programmed death-1; PD-L1, programmed death ligand 1; PD-L2, programmed death ligand 2; TCR, T-cell receptor; TFH, follicular helper T.
Figure 4
Subsets of T cells that promote or regulate B-cell help. TFH cells, critical for GC development and maturation, are reliant upon the transcription factor BCL6 for differentiation and function, as are extrafollicular T-helper cells that promote formation of the extrafollicular plasmablast response. Follicular helper iNKT cells, also reliant upon BCL6 for development, provide cognate help for B-cell maturation in extrafollicular foci and GCs—similar to TFH and extrafollicular T-helper cells, respectively—resulting in the production of class-switched and affinity-matured antibodies to lipids. By contrast, TFR cells regulate the TFH and GC B-cell responses, providing a brake on development of autoimmune reactions. As for their B-cell helper counterparts, TFR cells require BCL6 for development, but upregulate the BCL6 repressor, BLIMP-1, as well as expressing molecules associated with TREG-cell development and function, including FOXP3, CTLA4, GITR and IL-10. Abbreviations: BCL6, B-cell lymphoma 6; BLIMP-1, B-lymphocyte-induced maturation protein 1; CD40L, CD40 ligand; CTLA4, cytotoxic T-lymphocyte-associated antigen 4; CXCR4, CXC-chemokine receptor 4; CXCR5, CXC-chemokine receptor 5; FOXP3, forkhead box protein 3; GC, germinal center; GITR, glucocorticoid-induced TNF-receptor-related protein; ICOS, inducible T-cell co-stimulator; iNKT, invariant natural killer T; PD-1, programmed death-1; TCR, T-cell receptor; TFH, follicular helper T; TFR, follicular regulatory T; TREG, regulatory T.
Similar articles
- B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis.
Cortini A, Ellinghaus U, Malik TH, Cunninghame Graham DS, Botto M, Vyse TJ. Cortini A, et al. Ann Rheum Dis. 2017 Dec;76(12):2095-2103. doi: 10.1136/annrheumdis-2017-211499. Epub 2017 Aug 17. Ann Rheum Dis. 2017. PMID: 28818832 Free PMC article. - Follicular helper T cells are required for systemic autoimmunity.
Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, Schwartzberg PL, Cook MC, Walters GD, Vinuesa CG. Linterman MA, et al. J Exp Med. 2009 Mar 16;206(3):561-76. doi: 10.1084/jem.20081886. Epub 2009 Feb 16. J Exp Med. 2009. PMID: 19221396 Free PMC article. - IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.
Geginat J, Vasco M, Gerosa M, Tas SW, Pagani M, Grassi F, Flavell RA, Meroni P, Abrignani S. Geginat J, et al. Semin Immunol. 2019 Aug;44:101330. doi: 10.1016/j.smim.2019.101330. Epub 2019 Nov 15. Semin Immunol. 2019. PMID: 31735515 Review. - Excessive CD11c+Tbet+ B cells promote aberrant TFH differentiation and affinity-based germinal center selection in lupus.
Zhang W, Zhang H, Liu S, Xia F, Kang Z, Zhang Y, Liu Y, Xiao H, Chen L, Huang C, Shen N, Xu H, Li F. Zhang W, et al. Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18550-18560. doi: 10.1073/pnas.1901340116. Epub 2019 Aug 26. Proc Natl Acad Sci U S A. 2019. PMID: 31451659 Free PMC article. - Ex-TFRs: A Missing Piece of the SLE Puzzle?
Wei X, Zhang J, Zhou X. Wei X, et al. Front Immunol. 2021 Apr 9;12:662305. doi: 10.3389/fimmu.2021.662305. eCollection 2021. Front Immunol. 2021. PMID: 33897710 Free PMC article. Review.
Cited by
- B cells instruct their own fate through IL-12.
Sanz I. Sanz I. Nat Immunol. 2024 Aug;25(8):1310-1312. doi: 10.1038/s41590-024-01887-w. Nat Immunol. 2024. PMID: 38982286 No abstract available. - Research Progress of Natural Active Substances with Immunosuppressive Activity.
Shao F, Shen Q, Yang Z, Yang W, Lu Z, Zheng J, Zhang L, Li H. Shao F, et al. Molecules. 2024 May 16;29(10):2359. doi: 10.3390/molecules29102359. Molecules. 2024. PMID: 38792220 Free PMC article. Review. - An in vivo BSL-2 model for henipavirus infection based on bioluminescence imaging of recombinant Cedar virus replication in mice.
Huaman C, Clouse C, Rader M, Yan L, Bai S, Gunn BM, Amaya M, Laing ED, Broder CC, Schaefer BC. Huaman C, et al. Front Chem Biol. 2024;3:1363498. doi: 10.3389/fchbi.2024.1363498. Epub 2024 Mar 18. Front Chem Biol. 2024. PMID: 38770087 Free PMC article. - Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine.
Holm Hansen R, von Essen MR, Reith Mahler M, Cobanovic S, Sellebjerg F. Holm Hansen R, et al. Front Immunol. 2024 Feb 16;15:1327672. doi: 10.3389/fimmu.2024.1327672. eCollection 2024. Front Immunol. 2024. PMID: 38433828 Free PMC article. - Inhibition of Bcl-6 Expression Ameliorates Asthmatic Characteristics in Mice.
Zhou CZ, Xiong X, Tan WJ, Wang YF, Yang Z, Li XY, Yang XW, Liu XF, Yu SF, Wang LC, Geng S. Zhou CZ, et al. Curr Med Sci. 2024 Feb;44(1):110-120. doi: 10.1007/s11596-023-2800-z. Epub 2024 Jan 26. Curr Med Sci. 2024. PMID: 38277017
References
- Campbell DJ, Kim CH, Butcher EC. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat Immunol. 2001;2:876–881. - PubMed
- Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol. 2002;2:933–944. - PubMed
- Szabo SJ, et al. A novel transcription factor, T-bet, directs TH1 lineage commitment. Cell. 2000;100:655–669. - PubMed
- Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for TH2 cytokine gene expression in CD4 T cells. Cell. 1997;89:587–596. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR040072/AR/NIAMS NIH HHS/United States
- P30 AR053495/AR/NIAMS NIH HHS/United States
- R21 AR062842/AR/NIAMS NIH HHS/United States
- R01 AR44076/AR/NIAMS NIH HHS/United States
- R01 AR044076/AR/NIAMS NIH HHS/United States
- R01 AR40072/AR/NIAMS NIH HHS/United States
- R21 AR063942/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous